• Bookmark this Page
  • Print this Page

News Room

Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study

November 4, 2013

Reuters
November 4, 2013
Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study


Featuring:Dr. Steven Fishbane,  Chief, Division of Nephrology, North Shore-LIJ Health System


Read this Story

Back to Top